We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Ionis Pharmaceuticals beats Q4 earnings, eyes sHTG market with TRYNGOLZA. Strong pipeline and cash position make it a ...
Raymond James lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $60 from $61 and keeps a Strong Buy rating on the shares.
The Wichita Symphony presents "Dust + Ions" on Sunday, Feb. 23, 2025, at 3 p.m. Tickets start at $30. Students only $10. It ...
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients ...
EST Ionis Pharmaceuticals (IONS) trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what ...
In a paper published Wednesday, Chinese scientists claim to be able to extend the lifespan of lithium-ion batteries by “an ...
In a bold leap toward more sustainable energy storage, researchers at Worcester Polytechnic Institute have discovered a ...
The Wichita Symphony presents "Dust + Ions" on Sunday, Feb. 23, 2025, at 3 p.m. Tickets start at $30. Students only $10. It ...